AGFAF (Digicann Ventures) Beta: 3.7986 (As of Jun. 30, 2026)


What is Digicann Ventures Beta?

Digicann Ventures AGFAF Beta is 3.7986 as of Jun. 30, 2026. The stock has 1 warning sign investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-06-30), Digicann Ventures's Beta is 3.7986.

Digicann Ventures  (OTCPK:AGFAF) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)

Digicann Ventures Beta Related Terms

Digicann Ventures Beta Historical Data

* Premium members only.

The historical data trend for Digicann Ventures's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Digicann Ventures Beta Chart

Digicann Ventures Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.61 1.65 1.48 2.46 1.92

Digicann Ventures Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.42 1.80 2.15 1.92 3.60

AGFAF vs ZTS, UTHR, VTRS: Beta Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Digicann Ventures's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Digicann Ventures Beta vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Digicann Ventures's Beta distribution charts can be found below:

* The bar in red indicates where Digicann Ventures's Beta falls into.


Digicann Ventures Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 3.7986 mean?
Digicann Ventures (AGFAF) has a Beta of 3.7986 as of Jun. 30, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Digicann Ventures and its competitors.
Is Digicann Ventures' Beta too high?
Digicann Ventures' current Beta is 3.7986.
How does Digicann Ventures' Beta compare to ZTS and UTHR?
Digicann Ventures' Beta of 3.7986 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Drug Manufacturers company?
A good Beta depends on the Drug Manufacturers industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Digicann Ventures and its competitors. Digicann Ventures's current Beta is 3.7986. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Digicann Ventures stock overvalued right now?
Digicann Ventures (AGFAF) has a current Beta of 3.7986. The current Beta is 3.7986. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Digicann Ventures (AGFAF), the current Beta is 3.7986 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Digicann Ventures Business Description

Other Exchanges VY3:GermanyDCNN.X:Canada
Address 1075 West Georgia Street, Suite 1890, Vancouver, BC, CAN, V6E 3C9
Digicann Ventures Inc is a company focused on opportunities within and outside of the cannabis industry. The company focuses on identifying new business opportunities and operates in a single geographic location in Canada.